These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25822447)

  • 21. Herpes zoster in Crohn's disease during treatment with infliximab.
    Wang X; Zhao J; Zhu S; Xia B
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):237-9. PubMed ID: 24216569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional Brain Imaging Reveals Rapid Blockade of Abdominal Pain Response Upon Anti-TNF Therapy in Crohn's Disease.
    Hess A; Roesch J; Saake M; Sergeeva M; Hirschmann S; Neumann H; Dörfler A; Neurath MF; Atreya R
    Gastroenterology; 2015 Oct; 149(4):864-6. PubMed ID: 26264347
    [No Abstract]   [Full Text] [Related]  

  • 23. [Generalized pustulous psoriasis: A novel extraintestinal manifestation of Crohn's disease?].
    Canbay A; Rünzi M; Gieseler R; Alamouti D; von Kobyletzki G; Stücker M; Goebell H; Altmeyer P
    Z Gastroenterol; 2001 Sep; 39(9):801-5. PubMed ID: 11558073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infliximab: new preparation. A last resort for Crohn's disease.
    Prescrire Int; 2000 Dec; 9(50):163-5. PubMed ID: 11475490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease.
    Glas J; Török HP; Daczo J; Tonenchi L; Folwaczny M; Folwaczny C
    Eur J Med Res; 2005 Dec; 10(12):535-8. PubMed ID: 16356870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inadvertent yellow fever vaccination of a patient with Crohn's disease treated with infliximab and methotrexate.
    Ekenberg C; Friis-Møller N; Ulstrup T; Aalykke C
    BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27571912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uncommon Cause of Chest Pain in a 9-Year-Old Boy With Crohn's Disease.
    Kollen L; Werner O; Gavotto A
    Gastroenterology; 2020 Jun; 158(8):2055-2057. PubMed ID: 32145218
    [No Abstract]   [Full Text] [Related]  

  • 29. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
    Hyams J; Crandall W; Kugathasan S; Griffiths A; Olson A; Johanns J; Liu G; Travers S; Heuschkel R; Markowitz J; Cohen S; Winter H; Veereman-Wauters G; Ferry G; Baldassano R;
    Gastroenterology; 2007 Mar; 132(3):863-73; quiz 1165-6. PubMed ID: 17324398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.
    Baert F; Noman M; Vermeire S; Van Assche G; D' Haens G; Carbonez A; Rutgeerts P
    N Engl J Med; 2003 Feb; 348(7):601-8. PubMed ID: 12584368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: Medical therapy for fistulizing Crohn's disease.
    Bressler B; Sands BE
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1283-93. PubMed ID: 17059510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease.
    Kugathasan S; Werlin SL; Martinez A; Rivera MT; Heikenen JB; Binion DG
    Am J Gastroenterol; 2000 Nov; 95(11):3189-94. PubMed ID: 11095340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trial: impact of prior infliximab therapy on the clinical response to certolizumab pegol maintenance therapy for Crohn's disease.
    Hanauer SB; Panes J; Colombel JF; Bloomfield R; Schreiber S; Sandborn WJ
    Aliment Pharmacol Ther; 2010 Aug; 32(3):384-93. PubMed ID: 20491747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of Crohn's disease with anti-TNF alpha antibodies (infliximab): results of a multicentric and retrospective study].
    Doubremelle M; Bourreille A; Zerbib F; Heresbach D; Metman EH; Beau P; Gournay J; Galmiche JP
    Gastroenterol Clin Biol; 2002 Nov; 26(11):973-9. PubMed ID: 12483127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination therapy with infliximab and thiopurine compared to infliximab monotherapy in maintaining remission of postoperative Crohn's disease.
    Sakuraba A; Okamoto S; Matsuoka K; Sato T; Naganuma M; Hisamatsu T; Iwao Y; Ogata H; Kanai T; Hibi T
    Digestion; 2015; 91(3):233-8. PubMed ID: 25823572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maintenance therapy with certolizumab pegol for Crohn's disease.
    Schreiber S; Khaliq-Kareemi M; Lawrance IC; Thomsen OØ; Hanauer SB; McColm J; Bloomfield R; Sandborn WJ;
    N Engl J Med; 2007 Jul; 357(3):239-50. PubMed ID: 17634459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hidradenitis suppurativa and Crohn's disease: two cases that support an association.
    Yazdanyar S; Miller IM; Jemec GB
    Acta Dermatovenerol Alp Pannonica Adriat; 2010 Oct; 19(3):23-5. PubMed ID: 20976417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy.
    Oussalah A; Chevaux JB; Fay R; Sandborn WJ; Bigard MA; Peyrin-Biroulet L
    Am J Gastroenterol; 2010 May; 105(5):1142-9. PubMed ID: 20389296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
    Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful use of infliximab and tacrolimus in a patient with Crohn's disease.
    Cortes X; Borrás-Blasco J; Rodríguez J; Moreno M; Molés JR; Castera E
    Int J Clin Pharmacol Ther; 2015 Aug; 53(8):692-6. PubMed ID: 25997551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.